| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.005 | 1 |